RHUMBLINE ADVISERS - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$104,000
-51.6%
195,545
+11.9%
0.00%
-100.0%
Q4 2015$215,000
+0.9%
174,825
+19.8%
0.00%0.0%
Q3 2015$213,000
-22.3%
145,885
+3.7%
0.00%0.0%
Q2 2015$274,000
+7.5%
140,615
-0.3%
0.00%0.0%
Q1 2015$255,000
+3.2%
141,070
+34.6%
0.00%0.0%
Q4 2014$247,000
+0.4%
104,770
+3.2%
0.00%0.0%
Q3 2014$246,000
-13.7%
101,5200.0%0.00%0.0%
Q2 2014$285,000101,5200.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
PYRRHO CAPITAL MANAGEMENT, LP 608,194$1,186,0000.58%
Lombard Odier Asset Management (USA) Corp 2,768,341$5,398,0000.38%
Rotella Capital Management, Inc. 43,666$85,0000.07%
TWO SIGMA SECURITIES, LLC 19,994$39,0000.06%
OXFORD ASSET MANAGEMENT LLP 1,214,227$2,368,0000.06%
Candriam S.C.A. 1,445,000$2,818,0000.06%
WASHINGTON TRUST Co 410,616$801,0000.05%
DRW Securities, LLC 250,000$488,0000.05%
GLOBEFLEX CAPITAL L P 120,000$234,0000.04%
First Heartland Consultants, Inc. 74,624$146,0000.04%
View complete list of CTI BIOPHARMA CORP shareholders